| miRNA: a promising therapeutic target in cancer A Menon, N Abd-Aziz, K Khalid, CL Poh, R Naidu International journal of molecular sciences 23 (19), 11502, 2022 | 210 | 2022 |
| The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria K Khalid, CL Poh Vaccines 11 (7), 1264, 2023 | 36 | 2023 |
| The development of DNA vaccines against SARS-CoV-2 K Khalid, CL Poh Advances in Medical Sciences 68 (2), 213-226, 2023 | 17 | 2023 |
| Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting HX Lim, M Masomian, K Khalid, AU Kumar, PA MacAry, CL Poh International Journal of Molecular Sciences 23 (8), 4341, 2022 | 17 | 2022 |
| Development of next generation vaccines against SARS-CoV-2 and variants of concern AA Al-Fattah Yahaya, K Khalid, HX Lim, CL Poh Viruses 15 (3), 624, 2023 | 11 | 2023 |
| Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice K Khalid, HX Lim, A Anwar, SH Tan, JS Hwang, SK Ong, CL Poh AAPS PharmSciTech 25 (3), 60, 2024 | 2 | 2024 |
| Probiotics: A solution to the prevention of antimicrobial resistance CL Poh, K Khalid, HX Lim Antibiotics-Therapeutic Spectrum and Limitations, 595-609, 2023 | 1 | 2023 |
| Subphenotypes of Long COVID and the clinical applications of probiotics HX Lim, K Khalid, ADI Abdullah, LH Lee, RAR Ali Biomedicine & Pharmacotherapy 183, 117855, 2025 | | 2025 |
| A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions K Khalid, F Ahmad, A Anwar, SK Ong Molecular Biotechnology, 1-22, 2025 | | 2025 |
| The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2 K Khalid, HX Lim, JS Hwang, CL Poh The AAPS Journal 26 (5), 93, 2024 | | 2024 |